App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine—(TRACE)
Dörner L, Grosse L, Stange F, Hille H, Kurz S, Becker H, Volkmer S, Hippler M, Rieger D, Bombach P, Rieger J, Weinert L, Svensson L, Anders C, Cekin S, Paulsen F, Öner Ö, Ruhm K, Malek H, Möller Y, Tatagiba M, Wallwiener M, Eckert N, Escher P, Pfeifer N, Forschner A, Bauer A, Zips D, Bitzer M, Malek N, Gani C, Tabatabai G, Renovanz M. App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine—(TRACE). Neuro-Oncology Practice 2024, 11: 336-346. PMID: 38737615, PMCID: PMC11085831, DOI: 10.1093/nop/npae002.Peer-Reviewed Original ResearchHealth care professionalsHealth-related quality of lifePatient-reported outcomesAssessment of patient-reported outcomesQuality of lifePRO assessmentSystematic assessment of patient-reported outcomesAssessment of health-related quality of lifeElectronic PRO assessmentMedian distress scoreMayring's qualitative content analysisApp-based assessmentsEORTC QLQ-C30 instrumentHealth-related qualityBurden of symptomsPilot studyQualitative content analysisGlobal health scoreQLQ-C30 instrumentSmartphone applicationNeuro-oncology patientsSemi-structured interviewsInterdisciplinary expert panelCare professionalsPatient perspective